Mark Jit

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 53

Top Topics

Systematic Review

Cervical Cancer Screening

Respiratory Syncytial Virus

Top Venues

PLoS computational biology

Health technology assessment (Winchester, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Gabrielle Bonnet, John Bimba, Chancy Chavula, Harunavamwe N Chifamba, Titus Henry Divala, Andres G Lescano, Mohammed Majam, Danjuma Mbo, Auliya A Suwantika, Marco A Tovar, Pragya Yadav, Obinna Ikechukwu Ekwunife, Collin Mangenah, Lucky G Ngwira, Elizabeth L Corbett, Mark Jit, Anna Vassall
Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study. PLoS medicine 21 (7) (2024)
Gabrielle Bonnet, John Bimba, Chancy Chavula, Harunavamwe N Chifamba, Titus Henry Divala, Andres G Lescano, Mohammed Majam, Danjuma Mbo, Auliya A Suwantika, Marco A Tovar, Pragya Yadav, Obinna Ikechukwu Ekwunife, Collin Mangenah, Lucky G Ngwira, Elizabeth L Corbett, Mark Jit, Anna Vassall
Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study. PLoS medicine 21 (7) (2024)
Laurence S J Roope, Liz Morrell, James Buchanan, Alice Ledda, Amanda I Adler, Mark Jit, A Sarah Walker, Koen B Pouwels, Julie V Robotham, Sarah Wordsworth, null null
Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use. Communications medicine 4 (1) (2024)
Gabrielle Bonnet, John Bimba, Chancy Chavula, Harunavamwe N Chifamba, Titus Henry Divala, Andres G Lescano, Mohammed Majam, Danjuma Mbo, Auliya A Suwantika, Marco A Tovar, Pragya Yadav, Obinna Ikechukwu Ekwunife, Collin Mangenah, Lucky G Ngwira, Elizabeth L Corbett, Mark Jit, Anna Vassall
Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study. PLoS medicine 21 (7) (2024)
Shuo Feng, Julie Mclellan, Nicola Pidduck, Nia Wyn Roberts, Julian P T Higgins, Yoon Hong Choi, Alane Izu, Mark Jit, Shabir Ahmed Madhi, Edward Kim Mulholland, Andrew J Pollard, Simon R Procter, Beth Temple, Merryn Voysey
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis. Health technology assessment (Winchester, England) 28 (34) (2024)
Xinning Tong, Le Gao, Ian C K Wong, Vivien K Y Chan, Angel Y S Wong, Judith C W Mak, Jacqueline K Y Yuen, Mark Jit, Ivan F N Hung, Kai-Hang Yiu, Xue Li
Effects of sequential vs single pneumococcal vaccination on cardiovascular diseases among older adults: a population-based cohort study. International journal of epidemiology 53 (1) (2024)
Laurence S J Roope, Liz Morrell, James Buchanan, Alice Ledda, Amanda I Adler, Mark Jit, A Sarah Walker, Koen B Pouwels, Julie V Robotham, Sarah Wordsworth, null null
Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use. Communications medicine 4 (1) (2024)
Gabrielle Bonnet, John Bimba, Chancy Chavula, Harunavamwe N Chifamba, Titus Henry Divala, Andres G Lescano, Mohammed Majam, Danjuma Mbo, Auliya A Suwantika, Marco A Tovar, Pragya Yadav, Obinna Ikechukwu Ekwunife, Collin Mangenah, Lucky G Ngwira, Elizabeth L Corbett, Mark Jit, Anna Vassall
Cost-effectiveness of COVID rapid diagnostic tests for patients with severe/critical illness in low- and middle-income countries: A modeling study. PLoS medicine 21 (7) (2024)
Shuo Feng, Julie Mclellan, Nicola Pidduck, Nia Wyn Roberts, Julian P T Higgins, Yoon Hong Choi, Alane Izu, Mark Jit, Shabir Ahmed Madhi, Edward Kim Mulholland, Andrew J Pollard, Simon R Procter, Beth Temple, Merryn Voysey
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis. Health technology assessment (Winchester, England) 28 (34) (2024)
Shuo Feng, Julie Mclellan, Nicola Pidduck, Nia Wyn Roberts, Julian P T Higgins, Yoon Hong Choi, Alane Izu, Mark Jit, Shabir Ahmed Madhi, Edward Kim Mulholland, Andrew J Pollard, Simon R Procter, Beth Temple, Merryn Voysey
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis. Health technology assessment (Winchester, England) 28 (34) (2024)
Francis J Ruiz, Sergio Torres-Rueda, Carl A B Pearson, Eleanor Bergren, Chinyere C Okeke, Simon R Procter, Andres Madriz-Montero, Mark Jit, Anna Vassall, Benjamin S C Uzochukwu
What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in Nigeria. PLOS global public health 3 (3) (2023)
Simon R Procter, Bronner P Gonçalves, Proma Paul, Jaya Chandna, Farah Seedat, Artemis Koukounari, Raymond C W Hutubessy, Caroline Trotter, Joy E Lawn, Mark Jit
Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness. PLoS medicine 20 (3) (2023)
Emily Herrett, Keith Tomlin, Liang-Yu Lin, Laurie A Tomlinson, Mark Jit, Andrew Briggs, Michael Marks, Frank Sandmann, John Parry, Christopher Bates, Jessica Morley, Seb Bacon, Benjamin Butler-Cole, Viyaasan Mahalingasivam, Alan Dennison, Deb Smith, Ethan Gabriel, Amir Mehrkar, Alex J Walker, Liam Smeeth, Rosalind M M Eggo
Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT). BMJ open 13 (2) (2023)
Allison Portnoy, Rebecca A Clark, Matthew Quaife, Chathika Krishan Weerasuriya, Christinah Mukandavire, Roel Bakker, Arminder K Deol, Shelly Malhotra, Nebiat Gebreselassie, Matteo Zignol, So Yoon Sim, Raymond C W Hutubessy, Inés Garcia Baena, Nobuyuki Nishikiori, Mark Jit, Richard G White, Nicolas A Menzies
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study. PLoS medicine 20 (1) (2023)
Simon R Procter, Bronner P Gonçalves, Proma Paul, Jaya Chandna, Farah Seedat, Artemis Koukounari, Raymond C W Hutubessy, Caroline Trotter, Joy E Lawn, Mark Jit
Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness. PLoS medicine 20 (3) (2023)
Emily Herrett, Keith Tomlin, Liang-Yu Lin, Laurie A Tomlinson, Mark Jit, Andrew Briggs, Michael Marks, Frank Sandmann, John Parry, Christopher Bates, Jessica Morley, Seb Bacon, Benjamin Butler-Cole, Viyaasan Mahalingasivam, Alan Dennison, Deb Smith, Ethan Gabriel, Amir Mehrkar, Alex J Walker, Liam Smeeth, Rosalind M M Eggo
Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT). BMJ open 13 (2) (2023)
Emily Herrett, Keith Tomlin, Liang-Yu Lin, Laurie A Tomlinson, Mark Jit, Andrew Briggs, Michael Marks, Frank Sandmann, John Parry, Christopher Bates, Jessica Morley, Seb Bacon, Benjamin Butler-Cole, Viyaasan Mahalingasivam, Alan Dennison, Deb Smith, Ethan Gabriel, Amir Mehrkar, Alex J Walker, Liam Smeeth, Rosalind M M Eggo
Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT). BMJ open 13 (2) (2023)
Allison Portnoy, Rebecca A Clark, Matthew Quaife, Chathika Krishan Weerasuriya, Christinah Mukandavire, Roel Bakker, Arminder K Deol, Shelly Malhotra, Nebiat Gebreselassie, Matteo Zignol, So Yoon Sim, Raymond C W Hutubessy, Inés Garcia Baena, Nobuyuki Nishikiori, Mark Jit, Richard G White, Nicolas A Menzies
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study. PLoS medicine 20 (1) (2023)
Allison Portnoy, Rebecca A Clark, Matthew Quaife, Chathika Krishan Weerasuriya, Christinah Mukandavire, Roel Bakker, Arminder K Deol, Shelly Malhotra, Nebiat Gebreselassie, Matteo Zignol, So Yoon Sim, Raymond C W Hutubessy, Inés Garcia Baena, Nobuyuki Nishikiori, Mark Jit, Richard G White, Nicolas A Menzies
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study. PLoS medicine 20 (1) (2023)
Allison Portnoy, Rebecca A Clark, Matthew Quaife, Chathika Krishan Weerasuriya, Christinah Mukandavire, Roel Bakker, Arminder K Deol, Shelly Malhotra, Nebiat Gebreselassie, Matteo Zignol, So Yoon Sim, Raymond C W Hutubessy, Inés Garcia Baena, Nobuyuki Nishikiori, Mark Jit, Richard G White, Nicolas A Menzies
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study. PLoS medicine 20 (1) (2023)
Allison Portnoy, Rebecca A Clark, Matthew Quaife, Chathika Krishan Weerasuriya, Christinah Mukandavire, Roel Bakker, Arminder K Deol, Shelly Malhotra, Nebiat Gebreselassie, Matteo Zignol, So Yoon Sim, Raymond C W Hutubessy, Inés Garcia Baena, Nobuyuki Nishikiori, Mark Jit, Richard G White, Nicolas A Menzies
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study. PLoS medicine 20 (1) (2023)
Zhiyuan Hou, Xiaozhen Lai, Yang Liu, Mark Jit, Heidi Jane Larson, Hai Fang
Assessing the impact of the 2018 Changchun Changsheng vaccine incident on childhood vaccination in China. Communications medicine 3 (1) (2023)
Marina Antillón, Xiao Li, Lander Willem, Joke Bilcke, null null, Mark Jit, Philippe Beutels
The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach. PLoS medicine 20 (7) (2023)
Allison Portnoy, Jean-Louis Arcand, Rebecca A Clark, Chathika K Weerasuriya, Christinah Mukandavire, Roel Bakker, Edith Patouillard, Nebiat Gebreselassie, Matteo Zignol, Mark Jit, Richard G White, Nicolas A Menzies
The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study. PLoS medicine 20 (7) (2023)
Emily Herrett, Keith Tomlin, Liang-Yu Lin, Laurie A Tomlinson, Mark Jit, Andrew Briggs, Michael Marks, Frank Sandmann, John Parry, Christopher Bates, Jessica Morley, Seb Bacon, Benjamin Butler-Cole, Viyaasan Mahalingasivam, Alan Dennison, Deb Smith, Ethan Gabriel, Amir Mehrkar, Alex J Walker, Liam Smeeth, Rosalind M M Eggo
Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT). BMJ open 13 (2) (2023)
Simon R Procter, Bronner P Gonçalves, Proma Paul, Jaya Chandna, Farah Seedat, Artemis Koukounari, Raymond C W Hutubessy, Caroline Trotter, Joy E Lawn, Mark Jit
Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness. PLoS medicine 20 (3) (2023)
Emily A Burger, Jean-François Laprise, Stephen Sy, Mary Caroline Regan, Kiesha Prem, Mark Jit, Marc Brisson, Jane J Kim
Now or later: Health impacts of delaying single-dose HPV vaccine implementation in a high-burden setting. International journal of cancer 151 (10) (2022)
Xiao Li, Joke Bilcke, Liliana Vázquez Fernández, Louis Bont, Lander Willem, Torbjørn Wisløff, Mark Jit, Philippe Beutels, null null
Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian Children. The Journal of infectious diseases 226 (Suppl 1) (2022)
Frank G Sandmann, Elise Tessier, Joanne Lacy, Meaghan Kall, Edwin Van Leeuwen, André Charlett, Rosalind M M Eggo, Gavin Dabrera, W John Edmunds, Mary E Ramsay, Helen Campbell, Gayatri Amirthalingam, Mark Jit
Long-Term Health-Related Quality of Life in Non-Hospitalized Coronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Comparison With Controls. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 75 (1) (2022)
Rosanna C Barnard, Nicholas G Davies, null null, Mark Jit, W John Edmunds
Modelling the medium-term dynamics of SARS-CoV-2 transmission in England in the Omicron era. Nature communications 13 (1) (2022)
Nikos I Bosse, Sam Abbott, Johannes Bracher, Habakuk Hain, Billy J Quilty, Mark Jit, null null, Edwin Van Leeuwen, Anne Cori, Sebastian Funk
Comparing human and model-based forecasts of COVID-19 in Germany and Poland. PLoS computational biology 18 (9) (2022)
Shelly Bolotin, Selma Osman, Stephanie L Hughes, Archchun Ariyarajah, Andrea C Tricco, Sumaiya Khan, Lennon Li, Caitlin Johnson, Lindsay Friedman, Nazish Gul, Rachel Jardine, Maryrose Faulkner, Susan J M Hahné, Jane M Heffernan, Alya Dabbagh, Paul A Rota, Alberto Severini, Mark Jit, David N Durrheim, Walter A Orenstein, William J Moss, Sebastian Funk, Nikki Turner, William Schluter, Jaleela S Jawad, Natasha S Crowcroft
In Elimination Settings, Measles Antibodies Wane After Vaccination but Not After Infection: A Systematic Review and Meta-Analysis. The Journal of infectious diseases 226 (7) (2022)
Nicholas G Davies, Stefan Flasche, Mark Jit, Katherine E Atkins
Modeling the effect of vaccination on selection for antibiotic resistance in Streptococcus pneumonia e. Science translational medicine 13 (606) (2021)
Nicholas G Davies, Sam Abbott, Rosanna C Barnard, Christopher I Jarvis, Adam J Kucharski, James D Munday, Carl A B Pearson, Timothy W Russell, Damien C Tully, Alex D Washburne, Tom Wenseleers, Amy Gimma, William Waites, Kerry L M Wong, Kevin van Zandvoort, Justin D Silverman, null null, null null, Karla DiazOrdaz, Ruth H Keogh, Rosalind M M Eggo, Sebastian Funk, Mark Jit, Katherine E Atkins, W John Edmunds
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science (New York, N.Y.) 372 (6538) (2021)
Allison Portnoy, Kaja M Abbas, Steven Sweet, Jane J Kim, Mark Jit
Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: a comparative modelling study. BMJ global health 6 (11) (2021)
Yang Liu, Frank G Sandmann, Rosanna C Barnard, Carl A B Pearson, null null, Roberta Pastore, Richard G Pebody, Stefan Flasche, Mark Jit
Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European Region. medRxiv : the preprint server for health sciences (2021)
Kiesha Prem, Kevin van Zandvoort, Petra Klepac, Rosalind M M Eggo, Nicholas G Davies, null null, Alex Richard Cook, Mark Jit
Projecting contact matrices in 177 geographical regions: An update and comparison with empirical data for the COVID-19 era. PLoS computational biology 17 (7) (2021)
Carl A B Pearson, Fiammetta Maria Bozzani, Simon R Procter, Nicholas G Davies, Maryam Huda, Henning Tarp Jensen, Marcus Keogh-Brown, Muhammad Khalid, Sedona Sweeney, Sergio Torres-Rueda, null null, null null, Rosalind M M Eggo, Anna Vassall, Mark Jit
COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness. PLoS medicine 18 (10) (2021)
Bronner P Gonçalves, Simon R Procter, Samuel Clifford, Artemis Koukounari, Proma Paul, Alexandra M Lewin, Mark Jit, Joy E Lawn
Estimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods. PLoS computational biology 17 (6) (2021)
Jessica Ochalek, Kaja M Abbas, Karl Claxton, Mark Jit, James Lomas
Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries. BMJ global health 5 (10) (2021)
Jaspreet Toor, Susy Echeverria-Londono, Xiang Li, Kaja Abbas, Emily D Carter, Hannah E Clapham, Andrew Clark, Margaret J de Villiers, Kirsten Eilertson, Matthew Ferrari, Ivane Gamkrelidze, Timothy B Hallett, Wes R Hinsley, Daniel Hogan, John H Huber, Michael L Jackson, Kévin Jean, Mark Jit, Andromachi Karachaliou, Petra Klepac, Alicia Kraay, Justin Lessler, Xi Li, Benjamin A Lopman, Tewodaj Mengistu, Charlotte Jessica E Metcalf, Sean M Moore, Shevanthi Nayagam, Timos Papadopoulos, T Alex Perkins, Allison Portnoy, Homie Razavi, Devin Razavi-Shearer, Stephen Resch, Colin Sanderson, Steven Sweet, Yvonne Tam, Hira Tanvir, Quan Tran Minh, Caroline L Trotter, Shaun A Truelove, Emilia Vynnycky, Neff Walker, Amy Winter, Kim Woodruff, Neil M Ferguson, Katy A M Gaythorpe
Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world. eLife 10 (2021)
Richard Gilson, Diarmuid Nugent, Kate Bennett, Caroline J Doré, Macey L Murray, Jade Meadows, Lewis J Haddow, Charles J Lacey, Frank G Sandmann, Mark Jit, Kate Soldan, Michelle Tetlow, Emilia Caverly, Mayura Nathan, Andrew J Copas
Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT. Health technology assessment (Winchester, England) 24 (47) (2021)
Rosanna C Barnard, Nicholas G Davies, null null, Mark Jit, W John Edmunds
Behaviour, booster vaccines and waning vaccine protection: modelling the medium-term dynamics of SARS-CoV-2 transmission in England. medRxiv : the preprint server for health sciences (2021)
Katy A M Gaythorpe, Kaja Abbas, John H Huber, Andromachi Karachaliou, Niket Thakkar, Kim Woodruff, Xiang Li, Susy Echeverria-Londono, null null, Matthew Ferrari, Michael L Jackson, Kevin McCarthy, T Alex Perkins, Caroline Trotter, Mark Jit
Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries. eLife 10 (2021)
Xinyu Zhou, Yi Song, Hao Jiang, Qian Wang, Zhiqiang Qu, Xiaoyu Zhou, Mark Jit, Zhiyuan Hou, Leesa Lin
Comparison of Public Responses to Containment Measures During the Initial Outbreak and Resurgence of COVID-19 in China: Infodemiology Study. Journal of medical Internet research 23 (4) (2021)
Yang Liu, Christian Morgenstern, James Kelly, Rachel Lowe, null null, Mark Jit
The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories. BMC medicine 19 (1) (2021)
Nicholas G Davies, Petra Klepac, Yang Liu, Kiesha Prem, Mark Jit, null null, Rosalind M M Eggo
Age-dependent effects in the transmission and control of COVID-19 epidemics. Nature medicine 26 (8) (2020)
Mark Jit, Dorothy Hui Lin Ng, Nantasit Luangasanatip, Frank Sandmann, Katherine E Atkins, Julie V Robotham, Koen B Pouwels
Quantifying the economic cost of antibiotic resistance and the impact of related interventions: rapid methodological review, conceptual framework and recommendations for future studies. BMC medicine 18 (1) (2020)
Billy J Quilty, Charlie Diamond, Yang Liu, Hamish Gibbs, Timothy W Russell, Christopher I Jarvis, Kiesha Prem, Carl A B Pearson, Samuel Clifford, Stefan Flasche, null null, Petra Klepac, Rosalind M M Eggo, Mark Jit
The effect of travel restrictions on the geographical spread of COVID-19 between large cities in China: a modelling study. BMC medicine 18 (1) (2020)
Nicholas G Davies, Stefan Flasche, Mark Jit, Katherine E Atkins
Within-host dynamics shape antibiotic resistance in commensal bacteria. Nature ecology & evolution 3 (3) (2019)
Irenjeet Bains, Yoon Hong Choi, Kate Soldan, Mark Jit
Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in England. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2019)
Mark Jit, Marc Brisson
Potential lives saved in 73 countries by adopting multi-cohort vaccination of 9-14-year-old girls against human papillomavirus. International journal of cancer 143 (2) (2018)
Kiesha Prem, Alex Richard Cook, Mark Jit
Projecting social contact matrices in 152 countries using contact surveys and demographic data. PLoS computational biology 13 (9) (2017)